– UK, Kings Lynn – BB Healthcare Trust plc (LON: BBH) today announced the appointment of Kate Bolsover to its Board as a Non-Executive Director with immediate effect.
“I am delighted to welcome Kate to the Board as a Non-Executive Director. Kate brings a wealth of experience particularly in investment trusts and at board level and we are confident that she will make a valuable contribution to the Company.” said Board Chairman, Randeep Grewal.
Ms. Bolsover will also be appointed as a member of the Audit and Risk Committee and the Management Engagement Committee.
About Kate Bolsover
Kate Bolsover has extensive experience in fund management with marketing, communications, and investment expertise. She previously worked for Cazenove Group plc and J.P. Morgan Cazenove between 1995 and 2005 where she was Managing Director of the mutual fund business, and latterly Director of Corporate Communications. Kate was also previously a Non-Executive Director of JP Morgan American Investment Trust plc until 2016, Chairman and Trustee of Tomorrow’s People until 2017, Senior Independent Director of Montanaro UK Smaller Companies Investment Trust Plc until 2019 and Chairman of Invesco Enhanced Income Limited until its merger with Invesco Bond Income Plus (previously City Merchant High Yield Trust Limited) in May 2021 at which time she joined the BIPS board as Senior Independent Director.
Kate is currently Chairman of Fidelity Asian Values Investment Trust plc, Non-Executive Director of TR Property Investment Trust plc, and Senior Independent Director of Invesco Bond Income Plus Limited. She is also a Non-Executive Director of Baillie Gifford & Co Limited (which acts as the Authorised Corporate Director and Alternative Investment Fund Manager for several Baillie Gifford managed funds).
For more information: http://www.bbhealthcaretrust.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.